Skip to main navigation Skip to search Skip to main content

Clinical performance of the AMDL DR-70™ immunoassay kit for cancer detection

  • Wu Dongfang
  • , Zhou Xin
  • , Yang Guoliang
  • , Xie Yuntao
  • , Hu Mingbai
  • , Wu Zhangqi
  • , Yang Gang
  • , Lu Minxiang
  • Department of Clinical Laboratory
  • Oncology Institute
  • Wuhan Institute of Virology

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Abstract

A clinical study using DR-70™ immunoassay for the detection of 13 different cancers have been conducted with 277 healthy subjects and 136 cancer patients. The test results showed that the DR-70™ immunoassay kit was capable of detecting cancers with high degree of specificity and sensitivity. At 95% specificity level, the sensitivity of the assay was 87.8%, 92.6%, 65.2% and 66.7%. respectively for lung, stomach, breast and rectum cancers. Furthermore the test kits were shown to be stable and performed reproducibly.
Original languageEnglish
Pages (from-to)63.0-72.0
Number of pages10
JournalJOURNAL OF IMMUNOASSAY
Volume19
Issue number1
DOIs
StatePublished - Jan 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Indexed by

  • Scopus

Fingerprint

Dive into the research topics of 'Clinical performance of the AMDL DR-70™ immunoassay kit for cancer detection'. Together they form a unique fingerprint.

Cite this